Stock listing
BOATS:ALLR Allarity Therapeutics, Inc. Stock
US listing (BOATS) of Allarity Therapeutics, Inc. · home listing NASDAQ:ALLR
Follow Allarity Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ALLR
$1.08 USD -0.05 (-4.4%)
Close on Nov 4, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ALLR
- Day range
- $1.07 – $1.18 USDNov 4, 2026
- Volume
- 135,808 sharesNov 4, 2026
- Market cap
- $17.18M USDAt the close on Nov 4, 2026 · price × 15.91M shares outstanding
- 52-week range
- $0.769 – $1.84 USDLowest and highest trades, Nov 5, 2025 – Nov 4, 2026
- Traded on an average day
- $129,204 USDMedian day 101,650 shares · last 3 months, Aug 4, 2026 – Nov 4, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ALLR · Home | $1.08 USD | -0.05 (-4.4%) | 135,808 | $1.15 | $1.18 | $1.07 | $1.13 | Close on Nov 4, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 4, 2026 · NASDAQ:ALLR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.08 | -0.05 | -4.4% | $1.15 | $1.18 | $1.07 | 135,808 | |
| $1.13 | +0.152 | +15.6% | $0.98 | $1.13 | $0.98 | 320,357 | |
| $0.978 | +0.107 | +12.3% | $0.874 | $1.03 | $0.874 | 166,742 | |
| $0.87 | -0.02 | -2.2% | $0.89 | $0.905 | $0.85 | 176,267 | |
| $0.89 | -0.06 | -6.3% | $0.938 | $0.938 | $0.854 | 150,036 | |
| $0.95 | +0.03 | +3.3% | $0.93 | $0.959 | $0.91 | 69,802 | |
| $0.92 | +0.005 | +0.5% | $0.93 | $0.96 | $0.90 | 136,055 | |
| $0.915 | +0.05 | +5.7% | $0.873 | $0.958 | $0.87 | 174,219 | |
| $0.865 | +0.019 | +2.2% | $0.842 | $0.896 | $0.84 | 70,570 | |
| $0.847 | -0.033 | -3.8% | $0.88 | $0.88 | $0.832 | 90,822 | |
| $0.88 | +0.004 | +0.4% | $0.873 | $0.902 | $0.84 | 88,643 | |
| $0.876 | +0.003 | +0.3% | $0.89 | $0.908 | $0.87 | 108,498 | |
| $0.873 | -0.022 | -2.5% | $0.898 | $0.915 | $0.821 | 86,465 | |
| $0.895 | +0.062 | +7.5% | $0.871 | $0.92 | $0.821 | 232,063 | |
| $0.833 | -0.041 | -4.6% | $0.897 | $0.90 | $0.80 | 323,178 | |
| $0.873 | +0.003 | +0.4% | $0.882 | $0.89 | $0.86 | 64,077 | |
| $0.87 | +0.01 | +1.2% | $0.88 | $0.91 | $0.83 | 111,400 | |
| $0.86 | -0.13 | -13.1% | $0.97 | $0.99 | $0.832 | 415,200 | |
| $0.99 | +0.008 | +0.8% | $0.995 | $1.04 | $0.99 | 97,000 | |
| $0.982 | -0.002 | -0.2% | $0.995 | $1.00 | $0.95 | 63,500 | |
| $0.984 | -0.001 | -0.1% | $1.02 | $1.04 | $0.981 | 81,000 | |
| $0.985 | -0.015 | -1.5% | $0.983 | $1.00 | $0.98 | 45,300 | |
| $1.00 | -0.04 | -3.8% | $1.04 | $1.05 | $0.99 | 39,100 | |
| $1.04 | 0.00 | 0.0% | $1.055 | $1.08 | $1.03 | 28,900 | |
| $1.04 | -0.01 | -1.0% | $1.06 | $1.079 | $1.01 | 74,100 | |
| $1.05 | +0.085 | +8.8% | $0.989 | $1.078 | $0.968 | 119,100 | |
| $0.965 | -0.003 | -0.3% | $0.972 | $1.00 | $0.94 | 167,600 | |
| $0.968 | -0.062 | -6.0% | $1.03 | $1.083 | $0.901 | 270,900 | |
| $1.03 | -0.06 | -5.5% | $1.09 | $1.10 | $1.03 | 43,700 | |
| $1.09 | +0.05 | +4.8% | $1.06 | $1.09 | $1.03 | 75,000 | |
| $1.04 | -0.07 | -6.3% | $1.15 | $1.15 | $1.01 | 167,500 | |
| $1.11 | -0.06 | -5.1% | $1.17 | $1.23 | $1.10 | 182,900 | |
| $1.17 | -0.04 | -3.3% | $1.20 | $1.20 | $1.13 | 114,900 | |
| $1.21 | +0.05 | +4.3% | $1.15 | $1.22 | $1.11 | 185,600 | |
| $1.16 | +0.005 | +0.4% | $1.13 | $1.267 | $1.13 | 160,400 | |
| $1.155 | +0.045 | +4.1% | $1.13 | $1.20 | $1.11 | 53,500 | |
| $1.11 | -0.06 | -5.1% | $1.16 | $1.195 | $1.09 | 154,500 | |
| $1.17 | -0.05 | -4.1% | $1.20 | $1.23 | $1.17 | 112,600 | |
| $1.22 | -0.03 | -2.4% | $1.32 | $1.34 | $1.21 | 205,200 | |
| $1.25 | -0.012 | -1.0% | $1.29 | $1.35 | $1.22 | 79,300 | |
| $1.262 | +0.012 | +1.0% | $1.28 | $1.29 | $1.25 | 65,300 | |
| $1.25 | -0.17 | -12.0% | $1.36 | $1.374 | $1.25 | 236,600 | |
| $1.42 | -0.01 | -0.7% | $1.44 | $1.45 | $1.40 | 54,500 | |
| $1.43 | +0.02 | +1.4% | $1.43 | $1.48 | $1.39 | 43,800 | |
| $1.41 | -0.01 | -0.7% | $1.45 | $1.49 | $1.37 | 124,000 | |
| $1.42 | +0.01 | +0.7% | $1.41 | $1.43 | $1.37 | 54,000 | |
| $1.41 | 0.00 | 0.0% | $1.41 | $1.44 | $1.32 | 106,300 | |
| $1.41 | +0.03 | +2.2% | $1.38 | $1.46 | $1.35 | 139,600 | |
| $1.38 | +0.04 | +3.0% | $1.35 | $1.43 | $1.34 | 49,800 | |
| $1.34 | +0.01 | +0.8% | $1.36 | $1.41 | $1.34 | 44,600 | |
| $1.33 | -0.06 | -4.3% | $1.38 | $1.41 | $1.33 | 57,919 | |
| $1.39 | -0.03 | -2.1% | $1.42 | $1.42 | $1.37 | 32,852 | |
| $1.42 | -0.01 | -0.7% | $1.41 | $1.492 | $1.38 | 111,700 | |
| $1.43 | 0.00 | 0.0% | $1.41 | $1.49 | $1.39 | 78,600 | |
| $1.43 | +0.08 | +5.9% | $1.35 | $1.49 | $1.35 | 117,800 | |
| $1.35 | +0.01 | +0.7% | $1.36 | $1.36 | $1.252 | 52,400 | |
| $1.34 | -0.03 | -2.2% | $1.39 | $1.39 | $1.31 | 56,600 | |
| $1.37 | +0.01 | +0.7% | $1.41 | $1.41 | $1.35 | 48,100 | |
| $1.36 | -0.04 | -2.9% | $1.42 | $1.43 | $1.255 | 152,200 | |
| $1.40 | -0.03 | -2.1% | $1.46 | $1.46 | $1.36 | 65,800 | |
| $1.43 | +0.02 | +1.4% | $1.43 | $1.55 | $1.36 | 133,800 | |
| $1.41 | +0.02 | +1.4% | $1.41 | $1.42 | $1.35 | 75,700 | |
| $1.39 | -0.01 | -0.7% | $1.39 | $1.43 | $1.35 | 50,800 | |
| $1.40 | +0.07 | +5.3% | $1.33 | $1.40 | $1.33 | 84,500 | |
| $1.33 | +0.02 | +1.5% | $1.35 | $1.354 | $1.27 | 108,100 | |
| $1.31 | +0.04 | +3.1% | $1.30 | $1.35 | $1.29 | 117,400 |
- Ticker
- BOATS:ALLR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 30, 2026
Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue
Latest deck · May 8, 2026
Investor Presentation (May 2026)
Investor deck · 22 slides
Latest news
Allarity Therapeutics Secures First Commercial Agreement Under New CLIA Laboratory Services Strategy, Establishing Potential Path to Additional Recurring Revenue
Oct 30, 2026
Closed $0.87 (-2.2%) on Oct 30, 2026
Allarity Provides Update on Key Recent Advances Solidifying Drug Response Predictor® to Drive Stenoparib’s Clinical Development
Sep 30, 2026
Closed $1.05 (+8.8%) on Sep 30, 2026
Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
Sep 28, 2026
Closed $0.968 (-6.0%) on Sep 28, 2026
Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development
Sep 15, 2026
Closed $1.11 (-5.1%) on Sep 15, 2026
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
Sep 11, 2026
Closed $1.22 (-2.4%) on Sep 11, 2026
Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
Aug 14, 2026
Closed $1.37 (+0.7%) on Aug 14, 2026
Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration
Jul 7, 2026
Closed $1.13 (-5.8%) on Jul 7, 2026
Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic
Jun 30, 2026
Closed $1.29 (-0.8%) on Jun 30, 2026
Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026
Jun 18, 2026
Closed $1.43 (+6.7%) on Jun 18, 2026
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
May 15, 2026
Closed $1.43 (+5.9%) on May 18, 2026
Decks
Investor Presentation (May 2026)
Investor deck · 22 slides · May 8, 2026
Investor Presentation (May 2025)
Investor deck · 24 slides · May 2025
Corporate Update (February 2024)
Corporate update · 16 slides · February 2024
Investor Presentation (December 2023)
Investor deck · 45 slides · Dec 6, 2023
Allarity Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 106 in all · newest Oct 30, 2026 · oldest 2022
- Decks
- 13 decks · latest May 8, 2026
Where Allarity Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ALLR · Home listing | NASDAQ | United States | USD |
| BOATS:ALLR · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Allarity Therapeutics, Inc.